E. Ohman J:Or Asset Management Ab Vertex Pharmaceuticals Inc Transaction History
E. Ohman J:Or Asset Management Ab
- $4.03 Trillion
- Q2 2025
A detailed history of E. Ohman J:Or Asset Management Ab transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, E. Ohman J:Or Asset Management Ab holds 10,520 shares of VRTX stock, worth $5.04 Million. This represents 0.12% of its overall portfolio holdings.
Number of Shares
10,520
Previous 11,490
8.44%
Holding current value
$5.04 Million
Previous $5.57 Billion
15.92%
% of portfolio
0.12%
Previous 0.15%
Shares
30 transactions
Others Institutions Holding VRTX
# of Institutions
1,831Shares Held
233MCall Options Held
1.38MPut Options Held
1.08M-
Capital World Investors Los Angeles, CA28.5MShares$13.7 Billion2.34% of portfolio
-
Vanguard Group Inc Valley Forge, PA23.5MShares$11.3 Billion0.21% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$10.2 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA14.5MShares$6.96 Billion1.6% of portfolio
-
State Street Corp Boston, MA11.8MShares$5.65 Billion0.24% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $123B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...